Navigation Links
Long-term safety data on Lialda published in leading GI journal
Date:6/17/2008

Basingstoke, UK and Philadelphia, US June 17, 2008 Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced the publication of data from a randomized, long-term safety and tolerability study (study 303) of ulcerative colitis (UC) drug Lialda™ (mesalamine). The primary endpoints of this study were to assess the safety and tolerability of Lialda in mild-to-moderate UC patients over 12 months. Data were published in the July issue of Gut, the official journal of the British Society of Gastroenterology, a leading international journal in gastroenterology.

"This published data demonstrates that Lialda is generally well tolerated and has a strong safety profile," said Gary R. Lichtenstein, MD, co-author of study 303 and director of the Center for Inflammatory Bowel Diseases at the Hospital of the University of Pennsylvania. "Not only does this data demonstrate Lialda's safety and tolerability, but secondary endpoints from the maintenance phase of the 303 study show that a majority of patients on Lialda continued to remain in remission through 12 months."

Specifically, the primary endpoints of the Phase III, open-label, 12-month extension study were to evaluate the safety and tolerability of Lialda dosed once (2.4g/day) or twice daily (1.2g twice daily) over 12 months, including adverse events (AEs), treatment exposure, and time to withdrawal. AEs refer to any untoward medical occurrence that happens in a clinical trial patient. AEs can be "treatment-related" (TRAEs) and occur as a result of the study drug or they can be considered unrelated to the study drug. In study 303, all AEs were classified in one of three categories according to severity: mild, moderate, or severe.

Results of the study showed Lialda demonstrated a good safety profile, with 37.9 percent of patients (safety population n=459) experiencing AEs, the majority of which were mild or moderate in intensity. Treat
'/>"/>

Contact: Blythe Bertolo
bbertolo@golinharris.com
312-729-4463
Shire plc
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal
2. Some patients may not need insulin for long-term control of type 2 diabetes
3. New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
4. Social Security Statement Advises Seniors to Consider Private Long-Term Care Insurance, LTC Agency Reports; Medicare Wont Cover It
5. Treatment at an AASM accredited sleep center improves long-term CPAP compliance
6. Poor sleep a problem in long-term breast cancer survivors
7. Long-term pesticide exposure may increase risk of diabetes
8. Long-term bouts with hay fever worsen ability to breathe through your nose
9. Keane Wins $1.5 Million Electronic Medical Record (EMR) Implementation with Leading Long-Term Care Company
10. Long-term hormone replacement therapy increases breast cancer risk
11. Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... engines like Google Local and in front of their local customers ... Registration service offered by New Orleans based Webtyde Internet Marketing. ... ... In order to be competitive locally and nationally, businesses must have ... local map section in a major search engine, a business must ...
(Date:12/17/2009)... in Stauffer & Nathan law firm, litigators of complex personal injury ... practice , ... Tulsa, OK (Lexis Nexis) December 17, ... more than 20 years of experience handling personal injury and insurance ... one of the top attorneys in the state of Oklahoma for ...
(Date:12/16/2009)... If proposed health care legislation is enacted, it ... system. Approximately 18.4 million Californians and 161 million ... employer-based insurance for their health care coverage. ... legislation entail specific requirements for employer-based insurance. ... firms that currently comply with most new standards, ...
(Date:12/16/2009)... PARAMUS, N.J., Dec. 16 Smart Balance, Inc. ... of directors has authorized a two-year stock repurchase program ... ,, "The repurchase program demonstrates the confidence we have ... commitment to deliver long-term value for all of our ... of funds," said Stephen Hughes, Smart Balance, Inc. Chairman ...
(Date:12/16/2009)... -- Every year in the United States, 160,000 cases ... of the disease, making it the second leading cause ... , As researchers and clinicians fervently look for causes ... of studies producing more and more promising results ... genetics at Case Western Reserve University School of Medicine ...
Breaking Medicine News(10 mins):Health News:New Orleans Based Internet Marketing Is Helping Small Businesses Get a Chance to Shine On the Web 2Health News:Jody Nathan, Highly Regarded Tulsa Attorney, Named to 2009 Oklahoma Super Lawyers List 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:Smart Balance Authorizes Stock Repurchase Program 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3
... infrastructure and provide quality medical education, the government will ... of Rs.15.6 billion, it was announced Thursday. ,The ... Committee on Economic Affairs chaired by Prime Minister Manmohan ... and Kashmir, Uttar Pradesh and Jharkhand. ,The ...
... screening to identify people prone to brain strokes and urged ... ,On the eve of World Stroke Day, the ... widely and wrongly believed to be related to the heart ... know very little about strokes. It is still believed that ...
... in the AII India Institute of Medical Sciences (AIIMS) here ... ,The blaze broke out in the X-ray department ... after 1 a.M., they said., ,Fifteen fire tenders were ... control after around two hours., ,The X-ray wing was ...
... provided to children with special health care needs (CSHCN) ... their required need. //In addition, the poorer children have ... care needs met. These are the two most important ... of Public Health (HSPH) researchers, published in the June ...
... research has revealed that PMS, menopause and post natal depression ... // ,Research has revealed that although there are ... pre-menstrual syndrome (PMS), menopause and post natal depression (PND) are ... and psychology at the University of Western Sydney, Jane Ussher ...
... Hospital were been faced by the doctors – a report ... by the BMA in Northern Ireland, say a similar case ... found. A postal questionnaire addressed to all BMA workers in ... ,More than half doctors participated in the survey revealed ...
Other Medicine News:Health News:Health Care For Children With Special Needs Compromised 2
(Date:12/16/2009)... Scientific Corporation (NYSE: BSX ) today announced ... Connors as a Director. ,, Ms. Connors, ... division of Tyco International. Previously, she served as ... operations and general management. Prior to Eaton, Ms. ... management capacities with Ford, Chrysler and Mogami Denki, a ...
(Date:12/16/2009)... Dec. 16 CareCentrix, Inc ., ... management services, announced today that it has been ... DC-based health care accrediting organization that establishes quality ... guarantee that only appropriately trained, qualified clinical personnel ... a reasonable and timely appeals process is in ...
(Date:12/16/2009)... Greenway Medical Technologies, Inc. today announced that its ... management and interoperability solution, Prime Suite® 2011, ... annual 2009 Top 20 Best in KLAS ... ,, For practices having between six and 25 ... in KLAS in ambulatory EMR for the fourth ...
Breaking Medicine Technology:Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3CareCentrix Receives URAC Health Utilization Management Accreditation 2Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 2Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 3Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 4Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock 5303 1Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock 5303 2CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 1CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 2CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 3Lab on a Chip Might Speed Breast Cancer Monitoring 59092 1Lab on a Chip Might Speed Breast Cancer Monitoring 59092 2Lab on a Chip Might Speed Breast Cancer Monitoring 59092 3
... WIRE)--May 24, 2007 - Inovio Biomedical,Corporation (AMEX:INO), ... for cancers and infectious diseases and a ... announced today,that interim clinical trial results demonstrated ... technology was,safe and tolerable, facilitated gene expression, ...
... - Findings from an Otsuka Pharmaceutical Co, ... Association Annual Meeting -, SAN DIEGO, May ... study in,adolescents (13- 17 years old) with ... Squibb Company atypical,antipsychotic aripiprazole demonstrated significant improvement,compared ...
Other Medicine Technology:Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results 2Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results 3Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results 4Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results 5Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 2Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 3Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 4Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 5Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 7Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 8Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 9
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: